Zhao B - Search Results

1

Drug-associated porphyria: a pharmacovigilance study.

Wang Q, Zhuang JL, Han B, Chen M, Zhao B. Wang Q, et al. Among authors: zhao b. Orphanet J Rare Dis. 2024 Aug 1;19(1):286. doi: 10.1186/s13023-024-03294-8. Orphanet J Rare Dis. 2024. PMID: 39090656 Free PMC article.

2

Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.

Hu Y, Gong J, Zhang L, Li X, Li X, Zhao B, Hai X. Hu Y, et al. Among authors: zhao b. Int Immunopharmacol. 2020 Jul;84:106601. doi: 10.1016/j.intimp.2020.106601. Epub 2020 May 16. Int Immunopharmacol. 2020. PMID: 32422528

3

Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.

Chen G, Ning LJ, Qin Y, Zhao B, Mei D, Li XM. Chen G, et al. Among authors: zhao b. J Gastroenterol Hepatol. 2021 Jan;36(1):156-162. doi: 10.1111/jgh.15151. Epub 2020 Jul 3. J Gastroenterol Hepatol. 2021. PMID: 32542684

4

Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System.

Hu Y, Bai Z, Tang Y, Liu R, Zhao B, Gong J, Mei D. Hu Y, et al. Among authors: zhao b. J Diabetes Res. 2020 Jul 8;2020:3695101. doi: 10.1155/2020/3695101. eCollection 2020. J Diabetes Res. 2020. PMID: 32695827 Free PMC article.

5

Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data.

Chen G, Qin Y, Fan QQ, Zhao B, Mei D, Li XM. Chen G, et al. Among authors: zhao b. Cancer Med. 2020 Sep;9(18):6576-6585. doi: 10.1002/cam4.3198. Epub 2020 Jul 27. Cancer Med. 2020. PMID: 32720449 Free PMC article.

6

Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system.

Fan Q, Ma J, Zhang B, Li Q, Liu F, Zhao B. Fan Q, et al. Among authors: zhao b. Cancer Chemother Pharmacol. 2020 Nov;86(5):655-662. doi: 10.1007/s00280-020-04151-8. Epub 2020 Oct 1. Cancer Chemother Pharmacol. 2020. PMID: 33001273

7

Do sodium-glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real-world study.

Zhao B, Shen J, Zhao J, Pan H. Zhao B, et al. Among authors: zhao j. J Diabetes Investig. 2021 Aug;12(8):1400-1407. doi: 10.1111/jdi.13481. Epub 2021 Jan 17. J Diabetes Investig. 2021. PMID: 33325646 Free PMC article.

8

Guillain-Barré syndrome in patients treated with immune checkpoint inhibitors.

Fan Q, Hu Y, Wang X, Zhao B. Fan Q, et al. Among authors: zhao b. J Neurol. 2021 Jun;268(6):2169-2174. doi: 10.1007/s00415-021-10404-0. Epub 2021 Jan 21. J Neurol. 2021. PMID: 33475824

9

Clinical profile of acute pancreatitis following treatment with protease inhibitors: a real-world analysis of post-marketing surveillance data.

Qin W, Zhao B, Shang Y, Zhang L. Qin W, et al. Among authors: zhao b. Expert Opin Drug Saf. 2021 Sep;20(9):1109-1115. doi: 10.1080/14740338.2021.1933942. Epub 2021 Jun 1. Expert Opin Drug Saf. 2021. PMID: 34018864

10

Dropped head syndrome: a rare adverse drug reaction identified in the FDA adverse event reporting system and review of case reports in the literature.

Liu X, Zhao X, He Y, Tang Y, Yan XL, Zhao B, Dai Y. Liu X, et al. Among authors: zhao x, zhao b. Expert Opin Drug Saf. 2022 Oct;21(10):1329-1336. doi: 10.1080/14740338.2022.2054986. Epub 2022 Mar 22. Expert Opin Drug Saf. 2022. PMID: 35315301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,354 results

Search Page

Filters